Furosemide NDC 68094-867

NDC codes

FDA NDC Directory

Product NDC (as listed)68094-867Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68094-0867Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68094-867-62	68094086762	3 TRAY in 1 CASE (68094-867-62) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (68094-867-59)Marketed from Jan 28, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Furosemide
Generic name (nonproprietary): furosemide
Active ingredients: Furosemide — 40 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: Precision Dose Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070433
Marketing start: Jan 28, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 68094-867_1fbbdc90-7827-439a-8502-6f7a41a7c936SPL ID 1fbbdc90-7827-439a-8502-6f7a41a7c936SPL set ID 3fd02fb5-98a0-4eda-a0ec-41faabe04706RxCUI 197731UNII 7LXU5N7ZO5
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468094086762 followed by a unit qualifier and the quantity

Package 68094-0867-62. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 13, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Edema Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. Furosemide is particularly useful when an agent with greater diuretic potential is desired. Hypertension Oral furosemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with furosemide alone.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 070433

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 070433
Product	Strength	Form · route	Labeler	Product NDC
Furosemide	Furosemide 40 mg/5mL	SolutionOral	Atlantic Biologicals Corps	17856-3298
Furosemide	Furosemide 40 mg/5mL	SolutionOral	Hikma Pharmaceuticals USA Inc.	0054-3298